04 Addressing treatment resistance For patients who have not responded adequately to single-agent therapies, this combination could offer a new treatment option
GHK-Cu: The Copper Tripeptide With Gene-Regulatory Scope GHK-Cu is a naturally occurring tripeptide (glycine-histidine-lysine) that chelates copper ions
These five substances are tested: Marijuana (THC) and its metabolites, including THC-COOH Cocaine and its primary metabolite benzoylecgonine Opiates including heroin, morphine, and codeine Amphetamines including methamphetamine and MDMA Phencyclidine (PCP) Notice what is absent
advanced schedules raise frequency rather than single-dose size
Karagiannides I, Abdou R, Tzortzopoulou A, Voshol PJ, Kypreos KE, Apolipoprotein E
B: 30 minutes before beginning testing rats were given scopolamine directly into the brain intracerebroventricularly (ICV) and 10 minutes later Dihexa was given orally 1.25 mg kg day (low dose) and 2 mg/kg/day (high dose)